BD Epilor LOR syringe 7 ml with Luer-Lok nozzle, registration no. 10033430533 - Lots - attachment 의 안전성 경고

Agência Nacional de Vigilância Sanitária (ANVISA)에 따르면, 해당 안전성 경고 는 Brazil 에서 BECTON DICKINSON INDÚSTRIAS CIRÚRGICAS LTDA. 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

안전성 경고는 의료기기 제품과 관련된 중요한 정보와 권고사항을 담고 있습니다. 물론 안전성 경고가 배포되었다고 해서 해당 제품이 무조건 안전하지 않은 제품이라는 것은 아닙니다. 보건의료업계 종사자와 의료기기 사용자들에게 배포되는 안전성 경고에는 회수(recall)도 포함될 수 있습니다. 제조사가 안전성 경고를 작성하기도 하지만, 보건당국에서 작성하는 경우도 있습니다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Safety alert
  • 사례 ID
    1299
  • 날짜
    2013-09-04
  • 사례 국가
  • 사례 출처
    ANVISA
  • 사례 출처 URL
  • 비고 / 경고
    Brazilian data is current through June 2018. All of the data comes from Anvisa, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Brazil.
  • 데이터 추가 비고
    If the user does not detect the loss of resistance of the syringe due to the slip with greater resistance that the plunger may present, spinal anesthesia may occur instead of epidural anesthesia. If spinal anesthesia occurs, specific effects with a remote probability of occurrence include headaches and backaches, hypotension, urinary retention, and rare meningitis. Rare effects and unlikely occurrence include severe respiratory depression, hypotension, and decreased heart rate, which requires temporary advanced medical intervention with increased oxygen and administration of medications, or mechanical ventilation until the effects of anesthesia decrease. There are reports of cases in the literature without reports of studies with real incidence, presuming that these types of complications are very rare. In addition, the detection of specific and rarer effects should be part of the routine monitoring of patients receiving anesthesia.////// UPDATE 11/08/2014 - The company finalized the field action. An alert message was sent regarding the use of the product for customers and distributors.
  • 원인
    The bd has so far received 7 world reports indicating that the bd syringe epilor lor 7 ml with luer-lok nozzle may possibly slip with greater strength than usual for a resistance-loss plastic syringe during the ride within the syringe. this occurrence may make it difficult for the user to detect the loss of resistance when entering the epidural space. if this occurs, the user may continue to advance the syringe and needle through the epidural and dural space, and reach the spinal or intrathecal canal, resulting in spinal anesthesia rather than epidural anesthesia. there are no reports of harm to patients.
  • 조치
    The company that registers in Brazil, BD, recommends BD Epilor users to: 1. Follow the institution's standard routine procedure to ensure there is no resistance to the syringe before use; 2. If the syringe has this resistance, discard it and continue the procedure with a new syringe; 3. BD Brasil is available to clarify any technical doubts specific to this product and to provide the necessary assistance through the telephone 0800 055 5564 or the email crc@bd.com

Manufacturer